Shopping Cart
- Remove All
Your shopping cart is currently empty
MRZ 2-514 (8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one) is a strychnine-insensitive modulatory site of the NMDA receptor (glycineB)antagonist with Ki of 33 μM.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $88 | In Stock | |
| 5 mg | $213 | In Stock | |
| 10 mg | $347 | In Stock | |
| 25 mg | $689 | In Stock | |
| 50 mg | $1,160 | In Stock | |
| 100 mg | $1,560 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $235 | In Stock |
| Description | MRZ 2-514 (8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one) is a strychnine-insensitive modulatory site of the NMDA receptor (glycineB)antagonist with Ki of 33 μM. |
| Targets&IC50 | NMDA:33 μM (Ki), AMPA:72.7 μM |
| In vitro | MRZ 2-514 against peak AMPA-induced currents with IC50 values of 72.7 μM[1]. |
| In vivo | In mice, MRZ 2-514 has anticonvulsive action in the MES model, and the effect is prolonged by probenecid[1]. |
| Synonyms | 8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one |
| Molecular Weight | 308.09 |
| Formula | C11H6BrN3O3 |
| Cas No. | 202808-11-5 |
| Smiles | [O-][n+]1c2ccc(Br)cc2cc2c1c(=O)[nH][nH]c2=O |
| Relative Density. | 2.07 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 18.33 mg/mL (59.5 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.